Eiger BioPharmaceuticals (EIGRQ)
Company Profile
Quarter (USD) | Dec 23 | Sep 23 | Jun 23 | Mar 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 25.44 mm | 25.44 mm | 25.44 mm | 25.44 mm | 25.44 mm | 25.44 mm |
Cash burn (monthly) | 687.00 k | 29.83 k | 4.48 mm | 6.25 mm | 4.65 mm | 6.21 mm |
Cash used (since last report) | 9.66 mm | 419.58 k | 63.06 mm | 87.85 mm | 65.42 mm | 87.37 mm |
Cash remaining | 15.78 mm | 25.02 mm | -37.62 mm | -62.41 mm | -39.98 mm | -61.93 mm |
Runway (months of cash) | 23.0 | 838.7 | -8.4 | -10.0 | -8.6 | -10.0 |
13F holders | Current |
---|---|
Total holders | 3 |
Opened positions | 1 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 1.26 bn |
Total shares | 1.09 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Interwest Partners X | 935.43 k | $13.45 mm |
Propel Bio Management | 146.38 k | $1.24 bn |
Vivo Ventures VI | 4.17 k | $22.00 k |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
2 Nov 23 | Kayne Richard A | Common Stock | Buy | Acquire P | Yes | No | 0.2977 | 23,398 | 6.97 k | 5,375,225 |
1 Nov 23 | Kayne Richard A | Common Stock | Buy | Acquire P | Yes | No | 0.2797 | 100,000 | 27.97 k | 5,351,827 |
31 Oct 23 | Kayne Richard A | Common Stock | Buy | Acquire P | Yes | No | 0.2414 | 130,509 | 31.50 k | 5,251,827 |
31 Oct 23 | Kayne Richard A | Common Stock | Buy | Acquire P | Yes | No | 0.2615 | 12,345 | 3.23 k | 5,121,318 |
31 Oct 23 | Kayne Richard A | Common Stock | Buy | Acquire P | Yes | No | 0.2625 | 11,987 | 3.15 k | 5,108,973 |
31 Oct 23 | Leen Kawas | Common Stock | Buy | Acquire P | Yes | No | 0.2615 | 12,345 | 3.23 k | 4,391,432 |
31 Oct 23 | Leen Kawas | Common Stock | Buy | Acquire P | Yes | No | 0.2625 | 11,987 | 3.15 k | 4,379,087 |